Billingham ME - Search Results

1

Continuous infusion of angiopeptin significantly reduces accelerated graft vessel disease induced by FK 506 in a rat heart allograft model.

Meiser BM, Wolf S, Devens C, Wenke K, Thiery J, Kreuzer E, Hammer C, Billingham ME, Reichart B. Meiser BM, et al. Among authors: billingham me. Transplant Proc. 1992 Oct;24(5):1671-2. Transplant Proc. 1992. PMID: 1384201 No abstract available.

2

Simvastatin decreases accelerated graft vessel disease after heart transplantation in an animal model.

Meiser BM, Wenke K, Thiery J, Wolf S, Devens C, Seidel D, Hammer C, Billingham ME, Reichart B. Meiser BM, et al. Among authors: billingham me. Transplant Proc. 1993 Apr;25(2):2077-9. Transplant Proc. 1993. PMID: 7682363 No abstract available.

3

Effects of cyclosporin, FK506, and rapamycin on graft-vessel disease.

Meiser BM, Billingham ME, Morris RE. Meiser BM, et al. Among authors: billingham me. Lancet. 1991 Nov 23;338(8778):1297-8. doi: 10.1016/0140-6736(91)92594-r. Lancet. 1991. PMID: 1719321 Free article.

4

Initial experience with FK 506 as an immunosuppressant for nonhuman primate recipients of cardiac allografts.

Flavin T, Ivens K, Wang J, Gutierrez J, Hoyt EG, Billingham M, Morris RE. Flavin T, et al. Transplant Proc. 1991 Feb;23(1 Pt 1):531-2. Transplant Proc. 1991. PMID: 1703701 No abstract available.

5

Mycophenolate mofetil pharmacodynamics and pharmacokinetics correlate with rejection score in a BN-to-LEW heterotopic heart transplant model.

Klupp J, van Gelder T, Dambrin C, Regieli J, Boeke K, Billingham ME, Morris RE. Klupp J, et al. Among authors: billingham me. Transplant Proc. 2001 May;33(3):2170-1. doi: 10.1016/s0041-1345(01)02064-4. Transplant Proc. 2001. PMID: 11377490 No abstract available.

6

Pharmacodynamics of mycophenolic acid in heart allograft recipients: correlation of lymphocyte proliferation and activation with pharmacokinetics and graft histology.

Gummert JF, Barten MJ, van Gelder T, Billingham ME, Morris RE. Gummert JF, et al. Among authors: billingham me. Transplantation. 2000 Oct 15;70(7):1038-49. doi: 10.1097/00007890-200010150-00009. Transplantation. 2000. PMID: 11045640

7

Assessment of cardiac rejection and immunosuppression by magnetic resonance imaging and spectroscopy.

Walpoth BH, Lazeyras F, Tschopp A, Schaffner T, Althaus U, Billingham M, Morris R. Walpoth BH, et al. Transplant Proc. 1995 Jun;27(3):2088-91. Transplant Proc. 1995. PMID: 7792895 No abstract available.

8

Leflunomide abrogates accelerated heart allograft rejection in presensitized rats.

Cheung A, Billingham M, Sherwood S, Brazelton T, Shorthouse R, Morris R. Cheung A, et al. Transplant Proc. 1997 Feb-Mar;29(1-2):1294-5. doi: 10.1016/s0041-1345(96)00524-6. Transplant Proc. 1997. PMID: 9123313 Free article. No abstract available.

9

Different rates of cardiac and pulmonary rejection in combined heart-lung grafts in rats.

Prop J, Tazelaar HD, Billingham ME. Prop J, et al. Among authors: billingham me. Transplant Proc. 1987 Feb;19(1 Pt 2):1058. Transplant Proc. 1987. PMID: 3274274 No abstract available.

10

Studies in experimental models of chronic rejection: use of rapamycin (sirolimus) and isoxazole derivatives (leflunomide and its analogue) for the suppression of graft vascular disease and obliterative bronchiolitis.

Morris RE, Huang X, Gregory CR, Billingham ME, Rowan R, Shorthouse R, Berry GJ. Morris RE, et al. Among authors: billingham me. Transplant Proc. 1995 Jun;27(3):2068-9. Transplant Proc. 1995. PMID: 7792888 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

317 results

Search Page

Filters